H. Lundbeck A/S (HLBBF)
6.96
+0.32
(+4.82%)
USD |
OTCM |
Aug 27, 16:00
H. Lundbeck Debt to Equity Ratio : 0.3505 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3505 |
| March 31, 2026 | 0.4264 |
| December 31, 2025 | 0.468 |
| September 30, 2025 | 0.4933 |
| June 30, 2025 | 0.5642 |
| March 31, 2025 | 0.618 |
| December 31, 2024 | 0.6779 |
| September 30, 2024 | 0.1757 |
| June 30, 2024 | 0.1787 |
| March 31, 2024 | 0.1856 |
| December 31, 2023 | 0.199 |
| September 30, 2023 | 0.1859 |
| June 30, 2023 | 0.2291 |
| March 31, 2023 | 0.249 |
| December 31, 2022 | 0.2774 |
| September 30, 2022 | 0.3002 |
| June 30, 2022 | 0.3286 |
| March 31, 2022 | 0.3508 |
| December 31, 2021 | 0.2912 |
| September 30, 2021 | 0.3084 |
| June 30, 2021 | 0.3299 |
| March 31, 2021 | 0.3618 |
| December 31, 2020 | 0.4649 |
| September 30, 2020 | 0.5124 |
| June 30, 2020 | 0.5561 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5933 |
| December 31, 2019 | 0.5707 |
| September 30, 2019 | 0.034 |
| June 30, 2019 | 0.0342 |
| March 31, 2019 | 0.0363 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0779 |
| June 30, 2017 | 0.085 |
| March 31, 2017 | 0.1802 |
| December 31, 2016 | 0.1932 |
| September 30, 2016 | 0.2602 |
| June 30, 2016 | 0.3646 |
| March 31, 2016 | 0.3953 |
| December 31, 2015 | 0.4291 |
| September 30, 2015 | 0.4746 |
| June 30, 2015 | 0.3207 |
| March 31, 2015 | 0.2281 |
| December 31, 2014 | 0.2472 |
| September 30, 2014 | 0.1538 |
| June 30, 2014 | 0.161 |
| March 31, 2014 | 0.1617 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Novo Nordisk A/S | 0.6333 |
| ALK-Abello A/S | 0.0608 |
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.061B |
| Total Liabilities (Quarterly) | 3.952B |
| Shareholders Equity (Quarterly) | 4.109B |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 2.32% |